The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 501–600 of 1,001
Lamarche, B., & Desroches, S. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.1149s · Cited by 28
“The characterization of MS has been the topic of intense research over the past 15 y, leading to the identification of a series of other metabolic disturbances that are most frequently found in combination rather than in isolation in individuals with MS (5).”
BackgroundThe Effects of Menopause on Periodontal Tissue
Yıldırım, T. T., & Kaya, F. A. (2011) · International Dental Research · doi:10.5577/intdentres.2011.vol1.no3.2 · Cited by 28
“Multiple studies have demonstrated an association between postmenopausal status and increased levels of total cholesterol, low-density lipoprotein cholesterol (LDLC), lipoprotein(a), and decreased levels of highdensity lipoprotein-cholesterol (HDL-C) (19).”
BackgroundGhosh, J., Chaudhuri, D., Saha, I., & Chaudhuri, A. N. (2020) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_229_19 · Cited by 24
Management of Cardiovascular Risk in Perimenopausal Women with Diabetes
Kim, C. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0262 · Cited by 29
“While the menopausal transition itself is not associated with weight gain [7], women have redistribution of body fat resulting in a relative increase in visceral adiposity [8], in turn leading to unfavorable adipokine profiles [9], and subsequent insulin resistance and dyslipidemia [10].”
BackgroundXu, Y., Ma, X., Ding, J., Liu, Z., Song, Z., Liu, H., & Lin, N. (2014) · Rejuvenation Research · doi:10.1089/rej.2014.1557 · Cited by 24
“17 Consistently, OVX rats that were deficient for estrogen and developed obesity that could be reversed by E 2 replacement therapy, which decreased food intake and increased energy expenditure.”
Sohn, S. Y., Joung, J. Y., Cho, Y. Y., Park, S. M., Jin, S., Chung, J. H., & Kim, S. W. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.3.343 · Cited by 25
Battisti, S., Guida, F. M., Coppa, F., Vaccaro, D., Santini, D., Tonini, G., Zobel, B. B., & Semelka, R. C. (2014) · Clinical Breast Cancer · doi:10.1016/j.clbc.2014.02.003 · Cited by 25
Chuang, T.-J., Huang, C., Lee, C.-H., Hsieh, C., Hung, Y., Hung, C., Liang, Y., Chen, Y., Hsia, T., & Pei, D. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.03.008 · Cited by 24
Yousefi, H., Karimi, P., Alihemmati, A., Alipour, M. R., Habibi, P., & Ahmadiasl, N. (2017) · PubMed Central · doi:10.22038/ijbms.2017.9269 · Cited by 24
“The postmenopausal years are accompanied with an increase in glucose levels, and with rising visceral adiposity (1).”
BackgroundInfluentialDong, X.-L., Yu, W.-X., Li, C. M., Zhou, L., & Wong, M. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2050024x · Cited by 24
KASE, N. G., Friedman, E. G., Brodman, M. L., Kang, C., Gallagher, E. J., & LeRoith, D. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.05.051 · Cited by 28
The Relationship Between Menopause and Metabolic Syndrome: Experimental and Bioinformatics Analysis
Abir, J., Soltani, I., Bahia, W., Dandana, A., Hasni, Y., Miled, A., & Ferchichi, S. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10066-7 · Cited by 26
“In addition, increasing evidence indicated that this higher CVD and T2D risk in postmenopausal women are related to the increase in the MetS during the menopausal transition, beyond what is seen from aging alone (Carr 2003).”
BackgroundPerbedaan Gender pada Kejadian Sindrom Metabolik pada Penduduk Perkotaan di Indonesia
Bantas, K., Yoseph, H. K., & Moelyono, B. (2012) · Kesmas National Public Health Journal · doi:10.21109/kesmas.v7i5.44 · Cited by 24
Moreno, F. N., Campos-Shimada, L. B., da Costa, S. C., Garcia, R. F., Cecchini, A. L., Natali, M. R. M., Vitoriano, A. D. S., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/212378 · Cited by 31
“The postmenopausal state is a period in woman’s life that is accompanied by profound disturbances in lipid metabolism and a higher incidence of metabolic syndrome (MS) [1].”
BackgroundResultInfluentialGould, L. M. (2021) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/06ff-cc92 · Cited by 24
Barsalani, R., Brochu, M., & Dionne, I. J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.008 · Cited by 23
“the emergence of many cardiovascular risk factors and metabolic abnormalities in women [1].”
BackgroundKleis-Olsen, A.-S., Farlov, J. E., Petersen, E. A., Schmücker, M., Flensted-Jensen, M., Blom, I., Ingersen, A., Hansen, M., Helge, J. W., Dela, F., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14117 · Cited by 24
“2,10 Furthermore, the menopausal transition leads to vasomotor symptoms including hot flashes, night sweats, and sleep disturbances decreasing the quality of life in up to 80% of women.”
BackgroundHuynh, E., Wiley, E., Noguchi, K. S., Fang, H., Beauchamp, M., MacDonald, M. J., & Tang, A. (2024) · Women s Health · doi:10.1177/17455057241290889 · Cited by 30
Schindler, L. S., Subramaniapillai, S., Barth, C., van der Meer, D., Pedersen, M. L., Kaufmann, T., Maximov, I. I., Linge, J., Leinhard, O. D., Beck, D., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103239 · Cited by 32
“, 2008) and cardiometabolic diseases (Carr, 2003; Janssen et al., 2008; Pu et al., 2017), which may contribute to the observed post-menopausal risk for neurodegeneration and dementia (Brinton et al.”
Protein Biomarkers of Early Menopause and Incident Cardiovascular Disease
Ramirez, M. F., Honigberg, M. C., Wang, D., Parekh, J. K., Bielawski, K., Courchesne, P. L., Larson, M. G., Levy, D. A., Murabito, J. M., Ho, J. E., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028849 · Cited by 25
“30 In a cohort study of women through the menopause transition, changes in adipose tissue distribution were accompanied by increases in adiponectin, leptin, and CRP. 31 Whether similar changes in adipokine profile and adipose tissue distribution occur in women with early menopause has not been…”
Yin, W., Maguire, S. M., Pham, B., Garcia, A. N., Dang, N.-V., Liang, J., Wolfe, A., Hofmann, H. A., & Gore, A. C. (2015) · Endocrinology · doi:10.1210/en.2015-1032 · Cited by 24
Hussain, N. H. N., Sulaiman, S. A., Hassan, I. I., Kadir, A. A., Norhayati, M. N., Ismail, S. B., Yaacob, L. H., Zakaria, R., Shafie, N. S., Haron, J., et al. (2012) · Journal of Food Research · doi:10.5539/jfr.v1n2p171 · Cited by 23
“Postmenopausal status is also known to be associated with the emergence of metabolic syndrome which is characterized by central adiposity, insulin resistance and lipid abnormality (Carr, 2003).”
BackgroundHirose, A., Terauchi, M., Tamura, M., Akiyoshi, M., Owa, Y., Kato, K., & Kubota, T. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0021-4 · Cited by 23
“Background Middle-aged women are not only bothered by the physical and psychological symptoms of menopause, but are also at increased risk for cardiovascular diseases (CVDs), such as central obesity, hypertension, dyslipidemia, and diabetes [1-4], which are partly induced as a result of diminished estrogen production…”
BackgroundDaidzein improves insulin resistance in ovariectomized rats
Cao, Y., Zhang, S. F., Zou, S., & Xia, X. (2012) · Climacteric · doi:10.3109/13697137.2012.664831 · Cited by 23
Khang, A. R., Ku, E. J., Kim, Y. A., Roh, E., Bae, J. H., Oh, T. J., Kim, S. W., Shin, C. S., Kim, S. Y., & Kim, J. H. (2016) · Pituitary · doi:10.1007/s11102-016-0747-9 · Cited by 24
“We included a large number of old postmenopausal women in the hypopituitary and control group, and the menopausal status may affect the risk of metabolic syndrome [31].”
BackgroundWang, X., Wang, G., Rong, J., Wang, S. W., Ng, T. B., Zhang, Y. B., Lee, C., Lin, Z., Wong, H.-K., Yung, K. K. L., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00390 · Cited by 23
“…1994; Al-Safi and Santoro, 2014; Citraro et al., 2015), memory loss (Devi et al., 2005; Weber and Mapstone, 2009), bone resorption (Hernandez et al., 2003; Society, 2006), metabolic syndrome (Carr, 2003; Janssen et al., 2008), and colorectal cancer (Al-Azzawi and Wahab, 2002; Barzi et al., 2013).”
BackgroundBuscato, M., Davezac, M., Zahreddine, R., Adlanmérini, M., Métivier, R., Fillet, M., Cobraiville, G., Moro, C., Foidart, J., Lenfant, F., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00211.2020 · Cited by 23
Li, Q., Zheng, D., Lin, H., Zhong, F., Liu, J., Wu, Y., Wang, Z., Guan, Q., Zhao, M., Gao, L., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627903 · Cited by 23
“Post-menopausal status is also associated with an increased risk of metabolic syndrome (MS) (28), which is characterized by abdominal obesity, dyslipidaemia, hypertension, and diabetes, etc.”
BackgroundBays, H. E., Gonsahn-Bollie, S., Younglove, C., & Wharton, S. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100044 · Cited by 24
“…with obesity and increased visceral fat have higher TG and lower HDL-C levels [57], and both polycystic ovary syndrome [58] and menopause [59] increase the risk of the metabolic syndrome, for which high TG and low HDL-C are 2 of the 5 components (i.e., the other components being…”
BackgroundInsulin sensitivity: Gender-related differences in subjects with normal glucose tolerance
Schianca, G. P. C., Castello, L. M., Rapetti, R., Limoncini, A., & Bartoli, E. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.05.004 · Cited by 23
Koshy, S. M., Bobby, Z., Hariharan, A. P., & Sridhar, M. G. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31824e5bf7 · Cited by 26
Does metabolic syndrome or its components differ in naturally and surgically menopausal women?
Farahmand, M., Tehrani, F. R., Simbar, M., Mehrabi, Y., Khalili, D., & Azizi, F. (2013) · Climacteric · doi:10.3109/13697137.2013.856400 · Cited by 24
Migliaccio, S., Greco, E. A., Aversa, A., & Lenzi, A. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0030 · Cited by 23
“The onset of menopause is associated with several metabolic changes, and postmenopausal women fall into the same risk category as men for development of atherosclerosis and myocardial infarction [99].”
BackgroundRole of therapeutic fasting in women's health: An overview
Nair, P. M. K., & Khawale, P. (2016) · Journal of Mid-life Health · doi:10.4103/0976-7800.185325 · Cited by 28
“63 Journal of Mid-life Health ¦ Apr-Jun 2016 ¦ Vol 7 ¦ Issue 2 LDL particles; and (3) increased glucose and insulin levels.[34] Intermittent fasting (IF) has been evolved as a potential tool in redressing metabolic abnormalities as reported in various experimental studies.”
MethodGüdücü, N., Görmüş, U., Kutay, S. S., Kavak, Z. N., & Telatar, B. (2013) · PubMed · doi:10.3275/8881 · Cited by 27
Melatonin and Melatonergic Drugs in Clinical Practice
Srinivasan, V. J., Shillcutt, S. D., Öter, Ş., & Brzezinski, A. (2014) · Springer eBooks · doi:10.1007/978-81-322-0825-9 · Cited by 25
Makimura, H., Wei, J., Dolan-Looby, S. E., Ricchiuti, V., & Grinspoon, S. K. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.004 · Cited by 25
“In addition, as menopausal status is associated with age, changes in body composition and body fat distribution (29,30), insulin resistance (28) and the metabolic syndrome (31), it is not inconceivable that previous studies of RBP4 may have been confounded by this relationship.”
BackgroundEstrogens and Obesity: Is It All in Our Heads?
Hart-Unger, S., & Korach, K. S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.003 · Cited by 22
“In humans, population-based studies of postmenopausal women have shown that the risks of insulin resistance, fatty liver disease, and cardiovascular disease are increased compared to age-matched controls (Carr, 2003).”
BackgroundVCD-induced menopause mouse model reveals reprogramming of hepatic metabolism
Kumari, R., Ponte, M. E., Franczak, E., Prom, J. C., O’Neil, M. F., Sardiu, M. E., Lutkewitte, A. J., Christenson, L. K., Shankar, K., Morris, E. M., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101908 · Cited by 23
“However, as estrogen levels fall during menopause or reproductive senescence, females experience increased susceptibility to weight gain and metabolic disease onset [51].”
BackgroundA Prospective study on the incidence of metabolic syndrome in premenopausal and postmenopausal women
Mehndiratta, N., Sharma, S., Sharma, R., & Grover, S. (2020) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_57_19 · Cited by 22
“Metabolic syndrome is a clustering of impaired glucose metabolism, dyslipidemia, hypertension, and central obesity.[2]”
BackgroundThe association between mental health and obesity in postmenopausal women: A systematic review
Abdalla, M. M. I., Azzani, M., Atroosh, W. M. M., Anbazhagan, D., & Kumarasamy, V. (2022) · Endocrine Regulations · doi:10.2478/enr-2022-0032 · Cited by 23
Fat as a Friend or Foe of the Bone
Gruneisen, E., Kremer, R. B., & Duque, G. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00864-4 · Cited by 24
“Multiple studies found an association between an increase in central adiposity, insulin resistance, and cardiometabolic disease with the menopause state [111–113].”
Du, J., Liu, J., Wang, X., Wang, X., Ma, Y., Zhang, S., Li, Z., Ma, J., & Liu, J. (2025) · Biology Direct · doi:10.1186/s13062-025-00618-x · Cited by 23
Menopause and metabolic syndrome in obese individuals with binge eating disorder
Udo, T., McKee, S. A., White, M. A., Masheb, R. M., Barnes, R. D., & Grilo, C. M. (2014) · Eating Behaviors · doi:10.1016/j.eatbeh.2014.01.003 · Cited by 23
“Because MetS at postmenopausal has been strongly associated with various chronic medical conditions, such as cardiovascular disease (Carr, 2003; Ren & Kelley, 2009) and breast cancer (Agnoli, et al., 2010; Esposito, et al., 2013; Rosato, et al., 2011), emergence of metabolic abnormalities during…”
BackgroundGuo, K., Mogen, J., Struzzi, S., & Zhang, Y. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90691.2008 · Cited by 23
Estrogen suppresses adipogenesis by inhibiting S100A16 expression
Zhang, R., Su, D., Zhu, W., Huang, Q., Liu, M., Xue, Y., Zhang, Y., li, D., Zhao, A. Z., & Liu, Y. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0273 · Cited by 22
“In postmenopausal women, estrogen loss is an independent risk factor for more severe menopausal symptoms, such as metabolic disease, insulin resistance, and type 2 diabetes (Carr 2003, Manrique et al. 2012).”
BackgroundA High-Saturated-Fat, High-Sucrose Diet Aggravates Bone Loss in Ovariectomized Female Rats
Dong, X., Li, C., Cao, S., Zhou, L., & Wong, M. (2016) · Journal of Nutrition · doi:10.3945/jn.115.225474 · Cited by 22
“Estrogen deficiency in postmenopausal women leads to the development of bone loss and osteoporosis (3).”
Yang, Q., Song, C., Jiang, J., Chen, Y., Liang, S., Ma, N., Dong, K., Nie, W., & Wang, K. (2017) · Hypertension Research · doi:10.1038/hr.2017.86 · Cited by 22
Chen, J., Jia, Y., Liu, Y., Liu, J., Jiao, K., Teng, M., Hu, C., Zhen, J., Wu, M., Zhong, L., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.06.009 · Cited by 22
Miller, C. N., Yang, J., Avra, T. D., Ambati, S., Della‐Fera, M. A., Rayalam, S., & Baile, C. A. (2014) · Obesity · doi:10.1002/oby.20907 · Cited by 22
“including cardiovascular and hepatic diseases (1).”
Riesco, É., Tessier, S., Lacaille, M., Pérusse, F., Côté, M., Després, J., Bergeron, J., Weisnagel, J. S., Doré, J., & Mauriège, P. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31826f7ebf · Cited by 22
“M enopausal transition is often associated with increased intraabdominal fat deposition, deteriorated lipid-lipoprotein profile, higher glucose and insulin plasma levels,(1) and greater proinflammatory state,(2) now defined as metabolic syndrome.(3) In this context, adipose tissue (AT) secretes a number of factors (ad…”
BackgroundRelationships between obesity, lipids and fasting glucose in the menopause
Simoncig-Netjasov, A., Vujović, S., Ivović, M., Tančić‐Gajić, M., Marina, L., & Barać, M. (2013) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1302041s · Cited by 23
Clustering of cardiometabolic risk factors in Asian Indian women: Santiniketan women study
Bhagat, M., Mukherjee, S., De, P., Goswami, R., Pal, S., Das, M., & Ghosh, A. K. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181bfac28 · Cited by 22
“In many women, features of the metabolic syndrome (MS; abdominal adiposity, insulin resistance, and dyslipidemia) emerge with estrogen deficiency.(10) A review of risk factors that are common between men and women demonstrates some notable sex-dependent differences.”
BackgroundLin, K., Liou, T., Hsiao, L.-C., & Hwu, C. (2011) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2011.08.014 · Cited by 22
“014 abdominal obesity, dyslipidemia, and insulin resistance.(2) Homeostasis model assessment of insulin resistance (HOMAIR) is a surrogate estimate of directly measured insulin resistance based on measurements of fasting plasma glucose (PG) and insulin concentrations.”
BackgroundDiabetes prevalence in NZO females depends on estrogen action on liver fat content
Lubura, M., Hesse, D., Kraemer, M., Hallahan, N., Schupp, M., von Löffelholz, C., Kriebel, J., Rudovich, N. N., Pfeiffer, A. F. H., John, C., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2015 · Cited by 22
“However, if premenopausal women are compared with age-matched men, the differences are striking (6, 50).”
BackgroundCoşkun, T., Kosova, F., Arı, Z., Sakarya, A., & Kaya, Y. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.815 · Cited by 23
Kolovou, G. D., Anagnostopoulou, K. K., Pilatis, N. D., Giannopoulou, M., Hoursalas, I. S., Pavlidis, A. N., Adamopoulou, E., Valaora, A. I., Mikhailidis, D. P., & Cokkinos, D. V. (2004) · Journal of Women's Health · doi:10.1089/jwh.2004.13.1119 · Cited by 22
Qader, S. S., Shakir, Y. A., Nyberg, P., & Samsioe, G. (2008) · Climacteric · doi:10.1080/13697130802451787 · Cited by 22
Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women
Seon, M. J., Hwang, S. Y., Son, Y., Song, J., & Kim, O. Y. (2021) · Nutrients · doi:10.3390/nu13030865 · Cited by 21
“This hormone also has a direct effect on glucose uptake by the skeletal muscle and adipocytes, leading to the lowering of the blood glucose concentration [46,48].”
BackgroundJackson, K. C., Wohlers, L. M., Valencia, A. P., Cilenti, M., Borengasser, S. J., Thyfault, J. P., & Spangenburg, E. E. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-099 · Cited by 21
“However, significant reductions in female sex steroids in women are associated with a substantial increase in lipid accumulation surrounding the visceral region (Ferrara et al. 2002; Carr 2003).”
BackgroundMetabolic Messengers: oestradiol
Hevener, A. L., & Correa, S. M. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01317-7 · Cited by 21
“A reduction in circulating oestradiol concentration and impairment in target tissue action are thought to underlie the significant increase in metabolic disease incidence during this life phase 12–14 .”
Sornay‐Rendu, E., Karras-Guillibert, C., Munoz, F., Claustrat, B., & Chapurlat, R. D. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1469 · Cited by 22
Go, G., Tserendejid, Z., Lim, Y., Jung, S., Min, Y.-H., & Park, H. (2014) · Nutrition Research and Practice · doi:10.4162/nrp.2014.8.6.662 · Cited by 21
“Reduced dietary quality after menopause may be the cause of many other health problems and could make the postmenopausal syndrome worse [9].”
BackgroundSexual hormones and diabetes: The impact of estradiol in pancreatic β cell
Merino, B., & García‐Arévalo, M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.004 · Cited by 24
Cienfuegos, S., Gabel, K., Kalam, F., Ezpeleta, M., Lin, S., & Varady, K. A. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111545 · Cited by 21
The complementary roles of iron and estrogen in menopausal differences in cardiometabolic outcomes
Ahanchi, N. S., Khatami, F., Llanaj, E., Quezada‐Pinedo, H. G., Dizdari, H., Bano, A., Glišić, M., Eisenga, M. F., Marques-Vidal, P. M., & Muka, T. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.03.026 · Cited by 22
Gonadal steroid neuromodulation of developing and mature hypothalamic neuronal networks
Campbell, R. E., & Herbison, A. E. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.06.003 · Cited by 23
Prevalence and predictors of metabolic syndrome among Congolese pre- and postmenopausal women
Muchanga, S. M. J., Lepira, F. B., Longo, A. L., Sumaili, E. K., Makulo, J.-R. R., Mbelambela, E. P., Tozin, R. R., Ngatu, N. R., & Suganuma, N. (2013) · Climacteric · doi:10.3109/13697137.2013.856403 · Cited by 23
Alissa, E. M., Alnahdi, W. A., Alama, N., & Ferns, G. A. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.127 · Cited by 24
“Parity 0 5 (6) 2 (2) NS 1 1 (1) 0 (0) 2 2 (2) 2 (2) 3 4 (4) 4 (4) X4 78 (87) 82 (91)”
Yoon, L., Liu, Y., Park, H., & Kim, H. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3287 · Cited by 22
“Dyslipidemia, including hyperlipidemia, may be directly or indirectly associated with the metabolic states of estrogen-deficient females mentioned above.(2) Dyslipidemia is mainly manifested by elevations of total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyceride concentrations and a decrease in…”
BackgroundAdaptations with Intermittent Exercise Training in Post- and Premenopausal Women
Seidelin, K., Nyberg, M., Piil, P., Jørgensen, N. R., Hellsten, Y., & Bangsbo, J. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001071 · Cited by 23
“The metabolic syndrome is associated with increased blood levels of glycated hemoglobin (HbA1c) because of impaired blood glucose regulation (31) and increases in body fat as well as decreases in muscle mass (8).”
BackgroundMuhammad, F. Y., Gezawa, I., Uloko, A. E., Yakasai, A. M., Habib, A. G., & Iliyasu, G. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.046 · Cited by 21
Kim, J.-E., Choi, J., Park, J., Lee, J., Shin, A., Park, S. M., Kang, D., & Choi, J. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.12.012 · Cited by 25
Valicherla, G. R., Gupta, A. P., Hossain, Z. M., Riyazuddin, M., Syed, A. A., Husain, A., Lahiri, S., Dave, K. M., & Gayen, J. R. (2019) · Peptides · doi:10.1016/j.peptides.2019.170147 · Cited by 21
Heart Failure in Menopause: Treatment and New Approaches
da Silva, J. S., Montagnoli, T. L., de Sá, M. P. L., & Zapata‐Sudo, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315140 · Cited by 23
Female pattern hair loss: the relation to metabolic syndrome in premenopausal women
Zaki, M. S., & Ahmed, I. (2012) · Journal of the Egyptian Womenʼs Dermatologic Society · doi:10.1097/01.ewx.0000407128.10834.1e · Cited by 21
Lee, H.-J., & Lee, K.-H. (2013) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2013.42.9.1395 · Cited by 20
“삶의 질 저하와 관련성이 있다고 하였으며(51), Lee 등(20) 의 연구에서도 모든 식품군을 골고루 섭취한 그룹이 그렇지”
Data Informing Governing Body Resistance-Training Guidelines Exhibit Sex Bias: An Audit-Based Review
Pandit, A., Trần, T. B., Letton, M. E., Cowley, E. S., Gibbs, M. T., Wewege, M. A., & Hagstrom, A. D. (2023) · Sports Medicine · doi:10.1007/s40279-023-01878-1 · Cited by 23
“The prevalence of metabolic syndrome increases with menopause [57], as does cardiovascular disease risk [58].”
BackgroundFeigh, M., Andreassen, K. V., Hjuler, S. T., Nielsen, R. H., Christiansen, C., Henriksen, K., & Karsdal, M. A. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31827c58ab · Cited by 22
“T he human menopausal state is associated with increased visceral adiposity and related metabolic pathologies, including glucose intolerance, insulin resistance (IR), and development of type 2 diabetes.(1) Estrogen is highly involved in regulating energy balance and glucose metabolism in women,(2,3) and the estrogen d…”
BackgroundMechanisms of estrogen protection in diabetes and metabolic disease
Cignarella, A., & Bolego, C. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.084 · Cited by 22
Moor, V. J. A., Nansseu, J. R., Nouaga, M. E. D., Noubiap, J. J., Nguetsa, G. D., Tchanana, G., Ketcha, A., & Domgue, J. F. (2016) · Cardiology Journal · doi:10.5603/cj.a2015.0056 · Cited by 22
Laddu, D., Lee, V. R., Blew, R. M., Sato, T., Lohman, T. G., & Going, S. B. (2012) · PubMed · Cited by 24
Adeyanju, O. A., Soetan, O. A., Soladoye, A. O., & Olatunji, L. A. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0630 · Cited by 20
“Apart from degenerative diseases of the cardiovascular, skeletal, and central nervous systems, estrogen deficiency enhances metabolic derangement predisposing to obesity, T2DM and metabolic syndrome (Carr, 2003; Mauvais-Jarvis, 2011).”
BackgroundPark, J. M., Lee, H. S., Oh, J., & Lee, Y. (2019) · Journal of Women s Health · doi:10.1089/jwh.2018.7263 · Cited by 20
Chen, L., Hu, Z., Wang, X., Song, Y., Chen, Z., Zhang, L., Zheng, C., Vallis, J., Zhou, H., Cao, X., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870360 · Cited by 21
Xu, Y., Chen, T., Li, X., Qu, Y., An, J.-N., Zheng, H.-X., Zhang, Z., & Lin, N. (2016) · Aging · doi:10.18632/aging.101145 · Cited by 21
“Estradiol-17β (E2), a reproductive hormone, influences the growth, differentiation, and function of the female and male reproductive systems such as mammary gland, uterus, vagina, ovary, testes, epididymis, and prostate, and plays a vital role in body weight control [22].”
Chen, K. L. A., Zhao, Y. C., Hieronymi, K., Smith, B. P., & Madak-Erdogan, Z. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189911 · Cited by 19
Martins-Maciel, E. R., Campos-Shimada, L. B., Salgueiro‐Pagadigorria, C. L., Bracht, A., & Ishii‐Iwamoto, E. L. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.11.021 · Cited by 19
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow
Fernandes, C. E., Pompei, L. D. M., Machado, R. B., Ferreira, J. A. D. S., de Melo, N. R., & Peixoto, S. V. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.02.001 · Cited by 19
“An increase in insulin resistance and deterioration n glucose tolerance is known to occur with advancng age, although the effect of the menopause remains ontroversial [3].”
BackgroundRazmjou, S., Bastard, J., Doucet, É., RABASA-LHORET, R. P. R., Fellahi, S., Lavoie, J.-M., & Prud’homme, D. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000716 · Cited by 20
Bi, Y., Jiang, M., Guo, W., Guan, X., Xu, M., Ren, S., Yang, D., Gaikwad, N. W., Selcer, K. W., & Xie, W. (2018) · Endocrinology · doi:10.1210/en.2018-00531 · Cited by 19
Lipoprotein and metabolite associations to breast cancer risk in the HUNT2 study
Debik, J., Schäfer, H., Andreassen, T., Wang, F., Fang, F., Cannet, C., Spraul, M., Bathen, T. F., & Giskeødegård, G. F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01924-1 · Cited by 22
“dependent on the menopausal status [36-38], reflected in significantly higher cholesterol and total,”
BackgroundThe metabolic syndrome and its components in postmenopausal women
Chedraui, P. A., Miguel, G. S., Vintimilla-Sigüenza, I., Villacreses, D., Romero-Huete, L., Domínguez, A., Jaramillo, W., Escobar, G. S., Pérez-López, F. R., Genazzani, A. R., et al. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.788637 · Cited by 21
“and co-morbid conditions [5], possibly but not totally related to increasing estrogenic deficiency [6–8].”
BackgroundTucci, S., Flögel, U., & Spiekerkoetter, U. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.009 · Cited by 23
“Estrogens are known to protect against weight gain, obesity and dyslipidemia [55], however, a decline in estrogen levels after menopause or estrogen deficiency leads to a dysregulation of lipid and energy metabolism inducing metabolic changes that expose women to the same risk as men for the development of type 2 diab…”
BackgroundDiscontinuing Hormone Replacement TherapyAttenuating the Effect on CVD Risk With Lifestyle Changes
Gabriel, K. P., Kriska, A. M., CONROY, M., Johnson, B., Orchard, T. J., Goodpaster, B. H., Averbach, F. M., & Kuller, L. H. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.02.019 · Cited by 20
Jovancevic, J., Rosano, C., Perera, S., Erickson, K. I., & Studenski, S. A. (2012) · BMC Geriatrics · doi:10.1186/1471-2318-12-23 · Cited by 24
“[46-48] Adverse symptoms related to cognition, mood and sleep increase in frequency.”
BackgroundKretzschmar, J., Babbitt, D. M., Diaz, K. M., Feairheller, D. L., Sturgeon, K. M., Perkins, A., Veerabhadrappa, P., Williamson, S. T., Ling, C., Lee, H., et al. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000133 · Cited by 19
“Therefore, increases in these two lipid markers may not result from the onset of menopause but may simply be a function of age in this population, unlike previous reports.(3,37)”
ResultDifferences of Prevalence and Components of Metabolic Syndrome according to Menopausal Status
Joo, J. K., Son, J. B., Jung, J. E., Kim, S. C., & Lee, K. S. (2012) · Journal of Menopausal Medicine · doi:10.6118/jksm.2012.18.3.155 · Cited by 20
“실제로, 폐경에 따라 복부지방이 증가하며,(7) 고밀도 콜 레스테롤은 감소하고 총 중성 지방, 총 콜레스테롤, 저밀도 콜레스테롤은 증가하는 것으로 알려져 있다.(8) 이와 같은 체 내 지방 분포의 변화는 인슐린 저항성을 높이게 되며, 결과 적으로 폐경이 대사증후군의 위험인자로 작용함을 유추해 볼 수 있다.”
Bintvihok, W., Chaikittisilpa, S., Panyakamlerd, K., Jaisamrarn, U., & Taechakraichana, N. (2013) · Climacteric · doi:10.3109/13697137.2012.762762 · Cited by 19
Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury
Sivasinprasasn, S., Shinlapawittayatorn, K., Chattipakorn, S. C., & Chattipakorn, N. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9675-3 · Cited by 20
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.